172 related articles for article (PubMed ID: 6201871)
1. Human benign prostatic hyperplasia: etiological considerations.
Walsh PC
Prog Clin Biol Res; 1984; 145():1-25. PubMed ID: 6201871
[No Abstract] [Full Text] [Related]
2. Common characteristics of human and canine benign prostatic hyperplasia.
Isaacs JT
Prog Clin Biol Res; 1984; 145():217-34. PubMed ID: 6201876
[No Abstract] [Full Text] [Related]
3. Benign prostatic hyperplasia: etiological considerations.
Walsh PC
Prog Clin Biol Res; 1976; 6():1-8. PubMed ID: 66685
[TBL] [Abstract][Full Text] [Related]
4. [The role of tissue steroids in benign hyperplasia and prostate cancer].
Voigt KD; Bartsch W
Urologe A; 1987 Nov; 26(6):349-57. PubMed ID: 2448941
[TBL] [Abstract][Full Text] [Related]
5. [Endocrinologic factors in the development of benign prostatic hyperplasia].
Schweikert HU; Neumann F; Tunn UW
Urologe A; 1989 Nov; 28(6):317-20. PubMed ID: 2481357
[TBL] [Abstract][Full Text] [Related]
6. Benign prostatic hyperplasia in the nonhuman primate.
Lewis RW
Prog Clin Biol Res; 1984; 145():235-55. PubMed ID: 6201877
[No Abstract] [Full Text] [Related]
7. Steroid hormones and the pathogenesis of benign prostatic hyperplasia.
Griffiths K; Eaton CL; Harper ME; Peeling B; Davies P
Eur Urol; 1991; 20 Suppl 1():68-77. PubMed ID: 1722166
[TBL] [Abstract][Full Text] [Related]
8. Etiological considerations for the growth of stroma in benign prostatic hyperplasia.
Mawhinney MG
Fed Proc; 1986 Oct; 45(11):2615-7. PubMed ID: 2428672
[TBL] [Abstract][Full Text] [Related]
9. Transient hypertrophy of the ventral prostate and coagulating glands and accelerated thymic involution following pinealectomy in the mouse.
Vaughan MK; Reiter RJ
Tex Rep Biol Med; 1971; 29(4):579-86. PubMed ID: 4113015
[No Abstract] [Full Text] [Related]
10. [Steroid substances--androgens].
Shimazaki J; Fuse H; Akimoto S
Nihon Rinsho; 1986 Jan; 44(1):122-9. PubMed ID: 2421025
[No Abstract] [Full Text] [Related]
11. Biology of the prostate.
de Voogt HJ
Prog Clin Biol Res; 1991; 370():207-12. PubMed ID: 1718008
[No Abstract] [Full Text] [Related]
12. [Benign prostatic hyperplasia: a stromal disease].
Bartsch G; Brüngger A; Schweikert U; Hintner H; Höpfl R; Rohr HP
Urologe A; 1989 Nov; 28(6):321-8. PubMed ID: 2481358
[TBL] [Abstract][Full Text] [Related]
13. [Pathophysiology of benign prostatic hyperplasia].
Frick J
Wien Med Wochenschr; 1996; 146(8):158-60. PubMed ID: 8767399
[TBL] [Abstract][Full Text] [Related]
14. Anatomy of the prostate: insight into benign prostatic hyperplasia anatomy and pathogenesis.
Villers A
Prog Clin Biol Res; 1994; 386():21-30. PubMed ID: 7528390
[No Abstract] [Full Text] [Related]
15. Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.
Horton R
Am J Nephrol; 1982; 2(3):157-63. PubMed ID: 6184994
[No Abstract] [Full Text] [Related]
16. [Physiopathological aspects of the treatment of benign prostatic hypertrophy. Role of prostatic stroma and estrogens].
Solè-Balcells F
J Urol (Paris); 1993; 99(6):303-6. PubMed ID: 7516373
[TBL] [Abstract][Full Text] [Related]
17. The pathogenesis of BPH: role of hormones.
Griffiths K; Eaton CL
Prog Clin Biol Res; 1994; 386():33-41. PubMed ID: 7528401
[No Abstract] [Full Text] [Related]
18. Hormones and/or growth factors in prostate hypertrophy, pathophysiology and treatment.
Mathé G
Biomed Pharmacother; 1995; 49(7-8):317-8. PubMed ID: 8562855
[No Abstract] [Full Text] [Related]
19. Etiology of benign prostatic hyperplasia.
Lee C; Kozlowski JM; Grayhack JT
Urol Clin North Am; 1995 May; 22(2):237-46. PubMed ID: 7539172
[TBL] [Abstract][Full Text] [Related]
20. The role of estrogen/androgen synergism in the pathogenesis of benign prostatic hyperplasia.
Walsh PC
J Urol; 1988 Apr; 139(4):826. PubMed ID: 2451038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
